丰坦手术20年的经验:不良结果的风险因素
Tianyu Chen1, Linjiang Han1, Hailong Qiu1
1Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China; Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China.
概括
丰坦手术显示出良好的生存率,但异质性毒性增加了晚期失败的风险. 阶段性策略减少了早期死亡率,但并没有改善单胞体生理学患者的长期结果.
科学领域:
- 心脏病学 心脏病学
- 儿科心脏手术 儿科心脏手术
- 遗传性心脏病管理与管理
背景情况:
- 芬坦手术是一种复杂的手术,用于单心室生理学.
- 长期结果和风险因素需要进一步了解.
- 50年来,Fontan程序管理的重大演变.
研究的目的:
- 评估Fontan程序的早期和长期结果.
- 确定不良临床事件的风险因素.
- 评估分阶段Fontan战略的影响.
主要方法:
- 在400名接受Fontan手术的患者 (2004-2023) 的回顾性分析.
- 早期死亡风险因素的多变量逻辑回归.
- 对于长期Fontan故障预测器的Cox比例危险回归.
主要成果:
- 早期死亡率为5.5%. 5年,10年和15年的生存率分别为97.5%,92.6%和90.0%.
- 喘,单阶段全腔肺连接和延长的旁路时间预测了早期死亡率.
- 异质性是晚期Fontan失败的一个独立风险因素.
结论:
- 分阶段的Fontan策略减少了早期死亡率,但没有长期的结果.
- 异质毒性患者面临晚期Fontan失败的风险增加.
- 针对性管理对于高风险异种毒素群体至关重要.
相关概念视频
01:28Cardiac Catheterization I: Pre-Procedure Overview
1.1K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
1.1K
01:25Hemodialysis I: Introduction
1.4K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.4K